PharmGen Science Market Cap

PharmGen Science has a market cap or net worth of 78.01 billion as of March 9, 2026. Its market cap has decreased by -0.45% in one year.

Market Cap

78.01B

Enterprise Value

83.36B

Revenue

171.66B

Ranking

n/a

PE Ratio

662.50

Stock Price

3,560.00

Market Cap Chart

Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 78.01B, an increase of 616.21%. That is a compound annual growth rate of 6.66%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	78.01B	-14.32%
Dec 30, 2025	91.05B	22.74%
Dec 30, 2024	74.18B	-33.39%
Dec 28, 2023	111.36B	5.58%
Dec 29, 2022	105.47B	-33.88%
Dec 30, 2021	159.51B	-3.78%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	76.10T
Celltrion	46.51T
ALTEOGEN	19.95T
Sam Chun Dang Pharm.	17.77T
Enzychem Lifesciences	85.55B
Humasis	85.20B
Oncocross	85.15B
Ray Co., Ltd.	83.47B

Market Cap Rankings